文献速递慢病管理预防保健、筛查与疫苗

静脉血栓栓塞症初始治疗后的管理

Management of Patients With Venous Thromboembolism After the Initial Treatment Period.
PubMed 文献 · J Am Board Fam Med · 2021-01-01

本文面向基层医生,阐述静脉血栓栓塞症(VTE)患者完成初始3个月抗凝治疗后需关注的关键临床决策。核心是判断急性VTE症状是否已缓解,并评估复发风险与出血风险以决定停止或长期抗凝,强调医患共同决策。

要点

  • 抗凝满3个月后先判断急性VTE症状是否已缓解
  • 症状缓解后需权衡长期复发风险与潜在出血风险
  • 高风险患者考虑长期抗凝时应与患者共同决策

核心结论

  • 基层医生需在初始抗凝3个月后判断VTE症状是否缓解,并据复发与出血风险决定停药或长期抗凝。

研究设计与样本

  • 本文为面向基层医生的综述性文章,总结初始抗凝治疗结束后VTE患者的管理要点。

主要发现

  • VTE常见长期不良后果为复发性血栓栓塞和栓塞物不完全溶解,肺栓塞后可致肺动脉高压,深静脉血栓后可致腿部血栓后改变。

关键数值与推荐

  • 初始抗凝治疗满3个月后需评估症状是否缓解,并权衡长期复发风险与潜在出血风险以决定是否继续抗凝。

临床怎么用

  • 基层医生应首先确认急性VTE症状是否已缓解,再评估复发与出血风险,与高风险患者讨论长期抗凝的利弊并共同决策。

局限性

  • 本文为聚焦基层医生的综述性文章,非原始研究,未提供具体风险阈值或量化数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) is a common medical problem seen in primary care settings. The most common long-term adverse sequelae are recurrent thromboembolism and incomplete resolution of the embolic material, which may result in pulmonary hypertension after pulmonary embolism and post-thrombotic changes in the leg after deep vein thrombosis. Although there are detailed guidelines for diagnosing and treating acute VTE, there are few focused articles that provide recommendations for primary care physicians (PCPs) about how to manage VTE patients after completion of the initial period of anticoagulation treatment. OBSERVATIONS: In this article, we highlight several important clinical decisions that must be addressed after the first 3 months of anticoagulation treatment is complete, with a focus on particular management issues for PCPs. CONCLUSIONS: The 2 most important decisions the PCP must make are to determine, first, if symptoms of acute VTE have indeed resolved, and second, if they have resolved, to assess the long-term risk of recurrent VTE versus the risk of potential bleeding and decide if anticoagulation should be stopped, or if indefinite anticoagulation treatment is indicated. Among higher-risk patients who may benefit from indefinite anticoagulation, the PCP should discuss both the risks and benefits of anticoagulation treatment, empowering the patient to actively participate in this important shared decision-making process.

来源:J Am Board Fam Med,查看原文。版权归原作者所有。

引用

  1. Fernandes TM, Kanwar M, White R, et al. Management of Patients With Venous Thromboembolism After the Initial Treatment Period. J Am Board Fam Med. 2021. PMID: 33833011. doi:10.3122/jabfm.2021.02.200085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。